The DailyMed label for the Retatrutide Pen names three approved sites: abdomen, thigh, or upper arm
And if you see an effect in areas of the brain, or you see the EEG, the bandwidth changing, you infer that youre getting blood-brain barrier penetration
Strategies for minimizing muscle loss during use of incretinmimetic drugs for treatment of obesity
Retatrutide is still in clinical trials and has not been approved yet
Marquez-Meneses JD, Olaya-Bonilla SA, Barrera-Carreo S, Tibaduiza-Arvalo LC, Forero-Crdenas S, Carrillo-Vaca L, Rojas-Rodrguez LC, Calderon-Ospina CA, Rodrguez-Quintana J
Our Peptide Dosage Calculator guide provides worked examples across multiple vial sizes